Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-003804

Chief Executive Officer gave up 963 shares (to pay taxes)

  • Chief Executive Officer acquired 3,646 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Quart Barry D Chief Executive Officer 2021-01-13 Option exercise +3,646 92,872 D
Quart Barry D Chief Executive Officer 2021-01-13 Shares withheld for taxes −963 $18.16 $17,488 91,909 D
Derivatives
Quart Barry D Chief Executive Officer 2021-01-13 Option exercise · Restricted Stock Units −3,646 54,687 D
Loading xslF345X03/doc4.xml…